StockData
NervGen Pharma Corp. logo

NervGen Pharma Corp. (NGEN) SEC filings

NGENNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 40-F on Mar 31, 2026Score 5/30
$1.96+0.14 (+7.69%)

Close on Nov 17, 2026Market cap $156.11MP/E –Yield –

SEC filings

15 of NervGen Pharma's most recent filings on SEC EDGAR

DocumentFormPeriodFiledSource
Current report6-KSep 25, 2026Sep 25, 2026SEC EDGAR
Current report6-KSep 24, 2026Sep 24, 2026SEC EDGAR
Current report6-KAug 13, 2026Aug 13, 2026SEC EDGAR
Current report6-KJul 2, 2026Jul 2, 2026SEC EDGAR
Current report6-KJun 1, 2026Jun 1, 2026SEC EDGAR
Current report6-KMay 26, 2026May 26, 2026SEC EDGAR
Current report6-KMay 22, 2026May 22, 2026SEC EDGAR
Current report6-KMay 18, 2026May 18, 2026SEC EDGAR
Current report6-KMay 15, 2026May 15, 2026SEC EDGAR
Current report6-KApr 27, 2026Apr 27, 2026SEC EDGAR
Annual report40-FDec 31, 2025Mar 31, 2026SEC EDGAR
Current report6-KMar 13, 2026Mar 13, 2026SEC EDGAR
Current report6-KFeb 13, 2026Feb 13, 2026SEC EDGAR
Current report6-KFeb 10, 2026Feb 10, 2026SEC EDGAR
Current report6-KJan 8, 2026Jan 8, 2026SEC EDGAR

See a number that looks wrong?